The genomic landscape of fibrolamellar hepatocellular carcinoma: whole genome sequencing of ten patients.
about
Fibrolamellar Hepatocellular Carcinoma: Mechanistic Distinction From Adult Hepatocellular CarcinomaTranscriptomic characterization of fibrolamellar hepatocellular carcinoma.Hepatocellular Carcinoma, Fibrolamellar Variant: Diagnostic Pathologic Criteria and Molecular Pathology Update. A Primer.Fibrolamellar hepatocellular carcinoma: current clinical perspectives.From Clinical Standards to Translating Next-Generation Sequencing Research into Patient Care Improvement for Hepatobiliary and Pancreatic CancersComprehensive analysis of The Cancer Genome Atlas reveals a unique gene and non-coding RNA signature of fibrolamellar carcinoma.Characterization of potential driver mutations involved in human breast cancer by computational approaches.Hepatic adenomas with synchronous or metachronous fibrolamellar carcinomas: both are characterized by LFABP loss.Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells.A Proposed Physiopathological Pathway to Hyperammonemic Encephalopathy in a Non-Cirrhotic Patient with Fibrolamellar Hepatocellular Carcinoma without Ornithine Transcarbamylase (OTC) Mutation.DNAJB1-PRKACA fusion kinase interacts with β-catenin and the liver regenerative response to drive fibrolamellar hepatocellular carcinoma.CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1-Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma.Conformational Landscape of the PRKACA-DNAJB1 Chimeric Kinase, the Driver for Fibrolamellar Hepatocellular Carcinoma.Non coding RNA analysis in fibrolamellar hepatocellular carcinoma.Fibrolamellar Carcinoma: Recent Advances and Unresolved Questions on the Molecular Mechanisms.The DNAJB1-PRKACA chimera: Candidate biomarker and therapeutic target for fibrolamellar carcinomas.
P2860
Q28072292-41D0DC08-3941-4D4E-9785-B96FE10814C1Q36268536-A092DF0C-48A8-4B17-849C-768BD97FBD65Q36731897-8F360DA6-E2A4-4754-9AB7-FD9B39743CBEQ37031777-3CE8D79D-C8DB-4186-83C3-C9E9782E1FF8Q37631655-453338B5-0854-495E-B97C-5C649A083B72Q38901483-6782C4CF-A6B7-44D1-AE34-6DF4971F49CAQ39286993-0776D387-5BD5-4E91-8412-3038430EC60EQ39889043-60872064-7F29-459A-B93E-D699CD62D843Q41670848-8FF97989-4072-49AE-9A06-08552FD76E91Q42315206-9F349EA4-5275-449C-B223-BF5BCE5DCAEBQ47377422-AE299617-FAA1-4B82-8AD1-98581C07DED1Q47635386-D217B0CB-774A-470A-94B7-5D135EDF8734Q48240315-F2D055F8-2B51-456F-8E85-8C875D2CAEEDQ52657106-18FA6C90-6777-4490-8E01-573F1E4C8642Q52689575-86908910-43C5-43F4-B8DE-F134087D29C3Q54237690-73F63333-8B35-413B-AB4B-C8E2F723A082
P2860
The genomic landscape of fibrolamellar hepatocellular carcinoma: whole genome sequencing of ten patients.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The genomic landscape of fibro ...... me sequencing of ten patients.
@ast
The genomic landscape of fibro ...... me sequencing of ten patients.
@en
The genomic landscape of fibro ...... me sequencing of ten patients.
@nl
type
label
The genomic landscape of fibro ...... me sequencing of ten patients.
@ast
The genomic landscape of fibro ...... me sequencing of ten patients.
@en
The genomic landscape of fibro ...... me sequencing of ten patients.
@nl
prefLabel
The genomic landscape of fibro ...... me sequencing of ten patients.
@ast
The genomic landscape of fibro ...... me sequencing of ten patients.
@en
The genomic landscape of fibro ...... me sequencing of ten patients.
@nl
P2093
P2860
P356
P1433
P1476
The genomic landscape of fibro ...... ome sequencing of ten patients
@en
P2093
David G Darcy
Jennifer M Murphy
Joshua N Honeyman
Michael P LaQuaglia
Rachel Chiaroni-Clarke
P2860
P304
P356
10.18632/ONCOTARGET.2712
P407
P577
2015-01-01T00:00:00Z